Aldred, EM. (Ed.). 2009. Pharmacology: A Handbook for Complementary Healthcare Professionals. Elsevier.
Allaby, M, et al. 1998. Oxford Dictionary of Plant Sciences. Oxford: Oxford University Press.
Atkinson, C, et al. 2006. “Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States.” Am. J. Clin. Nutr. 84, 587-93.
Austria, JA, et al, 2008. “Bioavailability of alphalinolenic acid in subjects after ingestion of three different forms of flaxseed.” J. Am. Coll. Nutr. 27:214-21.
Axelson, M, et al, 1982. “Origin of lignans in mammals and identification of a precursor from plants.” Nature 298: 659-60.
Berquin, IM, et al. 2008. “Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 269(2):363-377.
Blanchet, C, et al. 2005. “Fatty acid composition of wild and farmed Atlantic Salmon (salmo salar) and rainbow trout (Oncorhynchus mykiss).” Lipids. 40(5):529-531.
Calne RY, et al, 1989. “Cyclosporin A in Clinical Organ Grafting.” First Norther Ireland Kidney Research Fund Lecture.
Daly, CA, et al. 2010. “A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef.” Nutrition Journal. 9:10.
Domenichiello, AF, et al. 2016. “The effect of linoleic acid on the whole body synthesis rates of polyunsaturated fatty acids from α-linolenic and linoleic acid in free-living rats. Journal of Nutr. Biochem. 30:167-176.
Donaldson, MS. 2004. “Nutrition and cancer: a review of the evidence for an anti-cancer diet.” Nutrition Journal. 3:19.
Franco, OH, et al. 2005. “Higher dietary intake of lignans is associated with better cognitive performance in postmenopausal women.” J. Nutr. 135: 1190-95.
Fung, JJ, et al, 1991. “Adverse Effects Associated with the Use of FK 506.” Transplant. Proc. 23, 3105-3108.
Gao, S., & Wang, L. 1998. “Application of cyclodextrin in environmental science.” Huanjing Kexue 6, 80-86.
Gebauer SK, et al. 2006. “n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr. 83: S1526–35.
Goyal, A, et al. 2014. “Flaxseed and flaxseed oil: an ancient medicine & modern functional food.” J Food Sci Technology 51(9):1633-53.
Health Canada Monograph on Flaxseed. http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=219&lang=eng
Hedges, AR. 1998. “Industrial applications of cyclodextrins.” Chem. Rev. 98, 2035-44.
Javidi, A, et al. 2016. “The effect of flaxseed powder on insulin resistance and blood pressure in prediabetic individuals: A randomized controlled clinical trial.” J. Res. Med. Sci 21, 70.
Kristensen, M, et al. 2012. “Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depends on food type.” Nutrition & Metabolism 9 (8).
Kristensen, M, et al. 2013. “Flaxseed dietary fibers suppress postprandial lipemia and appetite sensation in young men.” Nutr. Metab. Cardiovasc Dis. 23 (2), 136-43.
Lunn, J. and Theobald, H.E. 2006. The Health Effects of Dietary Unsaturated Fatty Acids. Nutrition Bulletin, 31: 178-224.
Mazur, W, et al. 1996. “Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples.” Anal Biochem 233: 169-180.
Olendzki, BC, et al. 2014. “Anti-inflammatory diet as a treatment for inflammatory bowel disease: a case series report.” Nutr. J. 13:5.
Prasad, K. 1997. “Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed.” Mol. Cell Biochem. 168, 177-23.
Prasad, N, et al, 1999. Cyclodextrins inclusion for food, cosmetics and pharmaceuticals. European Patent Patent 1084625.
Pratico, D. 2001. “In vivo measurement of the redox state.” Lipids 36, S45-S47.
Raffaelli, B, et al, 2002. “Enterolignans.” J. Chromatogr. B. 777: 29-43.
Rajewski, RA & Szejtli, J. 1996. “Pharmaceutical applications of cyclodextrins. 2. in vivo drug delivery.” J. Pharm. Sci. 85, 1142-1169.
Reaney, MT, et al, Pending. Use of cyclic peptides from flaxseed for improving animal and human health. USA Patent US 61,577,217.
Simopoulos, AP. 2002. “The importance of the ratio of omega-6/omega-3 essential fatty acids.” Biomedicine & Pharmacotherapy. 56, 365-379.
Szejtli, J. 1998. “Introduction and general overview of cyclodextrin chemistry.” Chemical Reviews 1743-53.
Touillaud, MS, et al. 2007. “Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.” J. Natl. Cancer Inst. 99, 475-86.
University of Maryland Medical Center. 2017. http://www.umm.edu/health/medical/altmed/supplement/omega3-fatty-acids.
Vanharanta, M, et al. 1999. “Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.” Lancet 354, 2112-15.
Wieczorek, Z, et al, 1991. “Immunosuppressive activity of cyclolinopetide A.” Pept. Res. 4, 275-83.
Arachidonic Acid and Eicosanoids: https://www.youtube.com/watch?v=018PxnH702k
Introduction to Eicosanoids: http://tmedweb.tulane.edu/pharmwiki/doku.php/introduction_to_eicosanoids
Omega-3 and Omega-6 Families of Fatty Acids: https://en.wikipedia.org/wiki/File:EFA_to_Eicosanoid.png
Magee, E. 2011. WebMD: The benefits of flaxseed. http://www.webmd.com/diet/features/benefits-of-flaxseed.
Health Canada, Bureau of Nutritional Sciences. Summary of Health Canada’s Assessment of a Health Claim about Ground Whole Flaxseed and Blood Cholesterol Lowering. January 2014. https://www.canada.ca/en/health-canada/services/food-nutrition/food-labelling/health-claims/assessments/ground-whole-flaxseed-blood-cholesterol-lowering-nutrition-health-claims-food-labelling.html
Stony Brook University Seafood Mercury Database http://www.stonybrook.edu/commcms/gelfond/docs/Seafood%20Mercury%20Database.pdf
Health Canada Monograph on Flaxseed Oil. http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=flaxseed.lin.oil.huile&lang=eng
Sources for Arachidonic Acid Cascade: